Interferon Beta-1b for the Treatment of Multiple Sclerosis – More than 10 Years of Experience
, , , , , und
29. März 2019
Über diesen Artikel
Online veröffentlicht: 29. März 2019
Seitenbereich: 12 - 18
Eingereicht: 14. Nov. 2018
Akzeptiert: 05. März 2019
DOI: https://doi.org/10.2478/amma-2019-0003
Schlüsselwörter
© 2019 Laura Iulia Barcutean et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Barcutean, Laura Iulia
University of Medicine, Pharmacy, Sciences and Technology of Târgu MureşRomania
Mures County Emergency Clinical Hospital, Department of NeurologyTârgu Mureş, Romania
Maier, Smaranda
University of Medicine, Pharmacy, Sciences and Technology of Târgu MureşRomania
Mures County Emergency Clinical Hospital, Department of NeurologyTârgu Mureş, Romania
Bajko, Zoltan
University of Medicine, Pharmacy, Sciences and Technology of Târgu MureşRomania
Mures County Emergency Clinical Hospital, Department of NeurologyTârgu Mureş, Romania
Motataianu, Anca
University of Medicine, Pharmacy, Sciences and Technology of Târgu MureşRomania
Mures County Emergency Clinical Hospital, Department of NeurologyTârgu Mureş, Romania
Romaniuc, Andreea
Mures County Emergency Clinical Hospital, Department of NeurologyTârgu Mureş, Romania
Andone, Sebastian Razvan
Mures County Emergency Clinical Hospital, Department of NeurologyTârgu Mureş, Romania
Balasa, Rodica Ioana
University of Medicine, Pharmacy, Sciences and Technology of Târgu MureşRomania
Mures County Emergency Clinical Hospital, Department of NeurologyTârgu Mureş, Romania